2026-04-05 Activation of Nerve Growth Factor signaling limits the response to lenvatinib in hepatocellular carcinoma
2026-04-03 Endocrine disruptors reprogram hepatic metabolic and immune gene networks to promote hepatocellular carcinoma
2026-03-25 Malic enzyme 1 contributes to tumorigenesis and lenvatinib resistance in hepatocellular carcinoma via FSP1-dependent ferroptosis evasion
2026-03-20 ATGL sensitizes hepatocellular carcinoma cells to genotoxic drugs by modulating p53 acetylation/phosphorylation status
2026-03-12 Neoadjuvant transarterial chemoembolization with tyrosine kinase and immune checkpoint inhibitors improves survival from resectable hepatocellular carcinoma in a multicenter, retrospective study (GUIDANCE002)
2026-03-10 Synergistic immunotherapeutic effects of irreversible electroporation and CAR-NK cell therapy against hepatocellular carcinoma
2026-03-03 Transcriptional factor ZMYM3 promotes hepatocellular carcinoma metastasis by upregulating CTTN and inducing invadopodia formation
2026-03-03 Multi-omics analysis of NEDD1 in hepatocellular carcinoma: biological function, prognostic value, and clinical significance
2026-03-02 KCTD1 stabilizes c-Myc to upregulate PD-L1 and suppress anti-tumor immunity in hepatocellular carcinoma
2026-02-27 NSD2 inhibits the expression of PD-L1 via oxidative phosphorylation to control immune surveillance in hepatocellular carcinoma
2026-02-27 APOA2-mediated endothelial mesenchymal transition and cancer lipid metabolism reprogramming confers antiangiogenic drug resistance through TGF-β
2026-02-26 Tumor-associated CD19+ macrophages induce immunosuppressive microenvironment in hepatocellular carcinoma
2026-02-26 Development and validation of machine learning models for diagnosing hepatocellular carcinoma risk and survival in patients with diabetic cirrhosis
2026-02-26 A demethylation-driven gene signature predicts prognosis and therapeutic vulnerability in hepatocellular carcinoma
2026-02-25 Fractal analysis of hepatocellular carcinoma vasculature shows regional differences independent of vascular invasion
2026-02-17 Machine learning–based cfDNA fragmentation profiling using automated capillary electrophoresis for early detection of hepatocellular carcinoma
2026-02-14 Kinic index: an artificial intelligence-driven predictive model and multitarget drug discovery framework for hepatocellular carcinoma patients
2026-02-10 Safety and feasibility of liver maximum capacity assessment in patients undergoing transarterial chemoembolisation for hepatocellular carcinoma
2026-02-05 Quantification of overall tumor burden using longitudinal magnetic resonance imaging improves response assessment in orthotopic murine hepatocellular carcinoma models
2026-02-05 An interpretable machine learning model using routine clinical data for early recurrence prediction in hepatocellular carcinoma
2026-02-05 Conditional survival after radiofrequency ablation for early-stage hepatocellular carcinoma
2026-02-04 Machine learning-based prognostic model of stemness and angiogenesis-related genes for predicting prognosis and immune infiltration in patients with HCC
2026-02-03 Integrated multi-dataset screening to predict prognosis and identify immunotherapy gene targets in hepatocellular carcinoma patients
2026-01-30 Large-scale single-cell analysis and in silico perturbation reveal dynamic evolution of HCC: from initiation to therapeutic targeting
2026-01-30 LukS-PV targeting C5aR inhibits EMT in hepatocellular carcinoma via the BCL6/HDAC6/HSPD1 axis
2026-01-27 Humoral IgG1 responses to tumor antigens underpin clinical outcomes in immune checkpoint blockade
2026-01-27 Deep learning-based system to predict hepatocellular carcinoma resection volume using contrast-enhanced CT
2026-01-27 Prompt-mamba filtering networks for accurate hepatocellular carcinoma lesion segmentation in abdominal CT
2026-01-23 DTX1-mediated degradation of TUBB3 in Kupffer cells mitigates hepatocellular carcinoma progression by regulating M1/M2 polarization
2026-01-22 A deep learning radiopathomic signature predicts recurrence risk of hepatocellular carcinoma after hepatectomy
2026-01-20 Large-scale serum N-glycomics tracks N-glycosylation dynamics in hepatocellular carcinoma progression and enables early diagnosis
2026-01-20 TET1 suppresses hepatocellular carcinoma progression by modulating the PI3K/Akt signaling pathways
2026-01-20 Surgical resection versus non-surgical treatments for hepatocellular carcinoma with macrovascular invasion
2026-01-20 Evaluation of immuno-oncologic biomarkers and β-catenin expression in response of hepatocellular carcinomas to immunotherapy
2026-01-19 The role of histone demethylase PHF2 as a tumour suppressor in hepatocellular carcinoma by regulating SRXN1
2026-01-17 CDC25C downregulation suppresses HCC growth via mitochondrial stress-induced autophagy and apoptosis
2026-01-16 Translational evaluation of BUB1B as a precision medicine biomarker for hepatocellular carcinoma